The ideal candidate should have demonstrated experience in hematopoietic cell transplantation and immunotherapy with an active clinical research interest, as demonstrated by peer reviewed publications, in the application of transplantation and immunotherapy to the treatment of human disease. Applicants must have an MD degree (or foreign equivalent) and be American Board of Internal Medicine (ABIM) eligible or certified in Medical Oncology or Hematology (or foreign equivalent). In order to be eligible for University sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE), or equivalent as determined by the Secretary of Health and Human Services. Interested candidates should submit a curriculum vitae, a concise statement of career goals including a description of clinical research goals, and list of personal references, along with a letter of application addressed to: Dr. Marco Mielcarek. University of Washington is an affirmative action and equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, creed, religion, national origin, sex, sexual orientation, marital status, pregnancy, genetic information, gender identity or expression, age, disability, or protected veteran status. Commitment to Diversity The University of Washington is committed to building diversity among its faculty, librarian, staff, and student communities, and articulates that commitment in the UW Diversity Blueprint (http://www.washington.edu/diversity/diversity-blueprint/). Additionally, the University's Faculty Code recognizes faculty efforts in research, teaching and/or service that address diversity and equal opportunity as important contributions to a faculty member's academic profile and responsibilities (https://www.washington.edu/admin/rules/policies/FCG/FCCH24.html#2432). |
